Schrodinger's Pricing:Conceptual and Practical Challenges of Conditional PAS in the NICE Technology Appraisal of Lorlatinib for Untreated ALK-Positive Advanced Non-small-cell Lung Cancer (Review of TA1103): An External Assessment Group Perspective

Hodgson, Robert orcid.org/0000-0001-6962-2893 and Coughlan, Diarmuid orcid.org/0000-0002-5348-3750 (2026) Schrodinger's Pricing:Conceptual and Practical Challenges of Conditional PAS in the NICE Technology Appraisal of Lorlatinib for Untreated ALK-Positive Advanced Non-small-cell Lung Cancer (Review of TA1103): An External Assessment Group Perspective. Pharmacoeconomics. ISSN: 1179-2027

Metadata

Item Type: Article
Authors/Creators:
Dates:
  • Accepted: 18 January 2026
  • Published (online): 24 February 2026
Institution: The University of York
Academic Units: The University of York > Faculty of Social Sciences (York) > Centre for Reviews and Dissemination (York)
Date Deposited: 02 Mar 2026 12:00
Last Modified: 02 Mar 2026 12:00
Published Version: https://doi.org/10.1007/s40273-026-01593-5
Status: Published online
Refereed: No
Identification Number: 10.1007/s40273-026-01593-5
Open Archives Initiative ID (OAI ID):

Download

Published Version

Filename: s40273-026-01593-5.pdf

Description: s40273-026-01593-5

Licence: CC-BY-NC 2.5

CLICK TO DOWNLOAD [thumbnail of s40273-026-01593-5]

Export

Statistics

View Altmetric information about this item.


CORE (COnnecting REpositories)